NCT05466968View on ClinicalTrials.gov

Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2027

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Suxiao Jiuxin Pills

Suxiao Jiuxin Pills consists Rhizoma Ligustici (Chuan xiong) and Borneolum (Bing pian).

DRUG

The placebo of Suxiao Jiuxin Pills

The placebo of Suxiao Jiuxin Pills is similar to Suxiao Jiuxin Pills in appearance, smell, and taste.

Trial Locations (1)

+86250001

Xiaolu Li, Jinan

All Listed Sponsors
lead

Xiaolu Li

OTHER

NCT05466968 - Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter